Moyom Biotechnology Partners with WPP Group to Expand Aphranel's Brand Globally

Moyom Biotechnology plans a strategic partnership with WPP Group to expand Aphranel's "Poetics of Time" Brand Positioning.

Moyom Biotechnology, a medical technology company that delivers science-based solutions and sustainable innovation in healthcare, lately announced a strategic partnership with WPP Group, one of the world's leading global communications and creative networks.

The partnership focuses on the "Poetics of Time" brand framework and will further focus on the long-term development of Aphranel's global brand communications. "Poetics of Time" reflects Aphranel’s view that aesthetic medicine should prioritize respecting anatomy, material science, and long-term clinical benefit over the goal of preventing aging.

Moyom Biotechnology's core brand, Aphranel focuses on professional medical aesthetics applications for clinical use and is positioned as the first CaHA-based regenerative injectable to achieve regulatory approval in China. The brand's strategy is based on a return to essential medical concepts, highlighting structural support and long-term biological processes that are in sync with the natural cycle of time.

Headquartered in London, WPP Group operates in more than 100 countries worldwide, integrating capabilities across creative, media, public relations, digital, consulting, and artificial intelligence. With this new partnership, WPP will use its global resources and combined expertise to assist Aphranel in developing a clear, consistent, and internationally relevant, market-ready brand narrative, as well as communicating the values and underlying scientific and clinical approach of Poetics of Time to a broader professional audience.

The partnership with WPP is considered an important step in strengthening the brand's worldwide presence at the intersection of regenerative science and a clinically grounded, time-based medical philosophy. Moreover, Moyom Biotechnology stated that it will continue to collaborate with WPP to extend Aphranel's international reach while also building long-term brand trust and consistency across global markets.